The Sherwin-Williams Company earnings overview

SHW FY2026 Q1 · Calendar Q2 2026

The Sherwin-Williams Company

Sherwin-Williams delivered a first-quarter beat, driven by share-gain initiatives across all three reportable segments and disciplined pricing. Gross margin expanded for the 14th time in 15 quarters despite modest dilution from the Suvenil acquisition. Management maintained full-year guidance even while raising raw-material inflation expectations to low-mid single digits, betting that surgical pricing and cost discipline can absorb the impact. The balance between a credible beat-and-maintain trajectory and mounting cost headwinds from propylene and broader commodity inflation defines the investment debate.